Q&A | How to sequence CAR T-cell therapy and bispecific antibodies in R/R MM Multiple Myeloma Hub 817 подписчиков Скачать
Symposium | Next wave of immune-based therapies: What you need to know, which focused on R/R MM Скачать
Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma Скачать
What is the rationale for monitoring secondary malignancies after BCMA and CD19 CAR T-cell therapy? Скачать
What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma? Скачать
For a triple-class refractory patient entering 4L therapy, how to sequence BCMA/GPRC5D bispecifics? Скачать
For a triple-class refractory patient entering 4L therapy, how to sequence BCMA/GPRC5D bispecifics? Скачать
What is the rationale for combination venetoclax+Kd treatment in patients with t(11;14) RRMM? Скачать
What factors influence the adoption rates of novel MM therapies in Latin America? [Portuguese] Скачать
What impact does osseous vs hematogenous extramedullary MM have on patient outcomes? [Spanish] Скачать
Is birtamimab an option for patients with advanced AL amyloidosis at high risk for early death? Скачать
Which patients might benefit the most from isatuximab-based combinations in the relapsed setting? Скачать
Which patients might benefit the most from isatuximab-based combinations in the relapsed setting? Скачать
Is experience with ide-cel CAR-T in the real-world setting comparable to the KarMMa trial results? Скачать
What are the current and future strategies for maintenance therapy after autologous transplant? Скачать
What are the key considerations of the updated guidelines for early relapsed multiple myeloma? Скачать
Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of p... Скачать
Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learn... Скачать
In which scenarios a PI added to Rd maintenance could benefit patients with MM after auto-HSCT? Скачать
Could CTCs and tumor DNA be more sensitive than a BM aspirate to assess treatment response in MM? Скачать
After the CARDAMON trial update, what do we know about the role of ASCT and K maintenance in NDMM? Скачать
OCEAN phase III trial: Why the initial efficacy observed with melflufen + dex has not improved OS Скачать
Evaluating the addition of elotuzumab to KRd by MRD assessment: the future of MRD-guided treatment? Скачать
When sequencing therapies for RRMM, how can we identify which patients may benefit most from CAR-T? Скачать
Outcomes of triple-class exposed/refractory disease in real-world care: What is the current SoC? Скачать
How do MM cells develop resistance to BCMA-targeted agents? Can it be overcome in the clinic? Скачать
Which patients could benefit most from post-HSCT maintenance therapy with daratumumab single agent? Скачать
What challenges may occur when treating AL amyloidosis with Dara + VCd in a real-world setting? Скачать
How will studying the MM immune system and microenvironment help us understand drug resistance? Скачать
Roundtable discussion—Multiple Myeloma Hub Satellite Symposium: Should 'cure' be the goal for MM? Скачать
What are the major challenges for CAR T-cell therapies in Europe during the COVID-19 pandemic? Скачать
5 things you need to know when diagnosing and treating monoclonal gammopathy of renal significance Скачать
Why do we need better myeloablative conditioning regimens, and what alternatives are being explored? Скачать
How should we monitor risk of progression in patients achieving MRD negativity after auto-SCT? Скачать
Is VRd or RAd induction more efficacious for patients with NDMM undergoing risk-adapted auto-SCT? Скачать
![What are the latest updates to the Portuguese MM treatment guidelines? [Portuguese]](https://img.save4k.ru/pic/I9_xJuy5q4U/mqdefault.jpg)
![What factors influence the adoption rates of novel MM therapies in Latin America? [Portuguese]](https://img.save4k.ru/pic/4uyCF4nM5TM/mqdefault.jpg)
![What impact does osseous vs hematogenous extramedullary MM have on patient outcomes? [Spanish]](https://img.save4k.ru/pic/SmALZYfGxW0/mqdefault.jpg)
